INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,300,306 | +15.8% | 104,374 | +49.3% | 0.00% | +50.0% |
| Q2 2023 | $2,851,174 | +44.6% | 69,916 | +32.1% | 0.00% | 0.0% |
| Q1 2023 | $1,972,254 | +167.9% | 52,918 | +150.8% | 0.00% | +100.0% |
| Q4 2022 | $736,179 | -28.2% | 21,100 | +15.1% | 0.00% | 0.0% |
| Q3 2022 | $1,026,000 | +45.5% | 18,331 | +34.6% | 0.00% | 0.0% |
| Q2 2022 | $705,000 | -31.2% | 13,614 | -3.4% | 0.00% | 0.0% |
| Q1 2022 | $1,025,000 | -49.7% | 14,100 | -18.2% | 0.00% | -50.0% |
| Q4 2021 | $2,038,000 | -46.1% | 17,234 | -38.9% | 0.00% | -33.3% |
| Q3 2021 | $3,781,000 | -5.0% | 28,186 | +14.6% | 0.00% | -25.0% |
| Q2 2021 | $3,982,000 | +89.2% | 24,594 | -6.2% | 0.00% | +100.0% |
| Q1 2021 | $2,105,000 | +110.9% | 26,227 | +42.9% | 0.00% | +100.0% |
| Q4 2020 | $998,000 | +282.4% | 18,347 | +39.7% | 0.00% | – |
| Q3 2020 | $261,000 | -29.1% | 13,130 | -24.9% | 0.00% | – |
| Q2 2020 | $368,000 | +61.4% | 17,484 | -6.1% | 0.00% | – |
| Q1 2020 | $228,000 | -14.9% | 18,614 | +1.9% | 0.00% | – |
| Q4 2019 | $268,000 | +12.6% | 18,264 | +110.2% | 0.00% | – |
| Q2 2018 | $238,000 | -9.8% | 8,688 | -30.6% | 0.00% | – |
| Q1 2018 | $264,000 | – | 12,527 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |